SEC Filing Summary: Amedica Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on December 19, 2016. The report covers the date of the earliest event reported, which is December 19, 2016. The registrant is incorporated in Delaware with principal executive offices in Salt Lake City, Utah.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of a corporate event rather than a financial statement.
Material Changes
Item 8.01 (Other Events) indicates that on December 19, 2016, the company issued a press release. The content of this press release is attached as Exhibit 99.1 and incorporated by reference. No other material changes to financial position or operations are detailed within the body of this specific filing.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or contingencies. These details are presumed to be contained within the referenced press release (Exhibit 99.1), which is not included in the provided input text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated December 19, 2016) to understand the specific nature of the "Other Event" reported.
- Verify the identity of the signatory, B. Sonny Bal, MD, who signed as Chief Executive Officer.
- Confirm the company's current status and any subsequent filings, as this 8-K only reports a single event date.
- Note that the input metadata lists "Sintx Technologies, Inc." but the filing text explicitly identifies the registrant as "Amedica Corporation"; verify the correct entity name for your records.